Cetera Advisor Networks LLC Surmodics Inc Transaction History

Cetera Advisor Networks LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$27.44 - $35.56 $4,664 - $6,045	-170 Reduced 1.0%	16,755 $491,000
Q4 2023 Feb 13, 2024	BUY	$28.47 - $38.49 $41,139 - $55,618	1,445 Added 9.33%	16,925 $615,000
Q3 2023 Nov 14, 2023	BUY	$28.28 - $38.36 $1,498 - $2,033	53 Added 0.34%	15,480 $496,000
Q2 2023 Aug 09, 2023	SELL	$17.67 - $31.31 $424 - $751	-24 Reduced 0.16%	15,427 $483,000
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $411 - $924	24 Added 0.16%	15,451 $351,000
Q2 2022 Aug 11, 2022	SELL	$33.25 - $45.11 $4,987 - $6,766	-150 Reduced 0.96%	15,427 $574,000
Q1 2021 May 17, 2021	BUY	$42.18 - $56.07 $6,327 - $8,410	150 Added 0.97%	15,577 $873,000
Q3 2018 Nov 14, 2018	BUY	$56.85 - $80.35 $877,024 - $1.24 Million	15,427 New	15,427 $1.15 Million

128

11.8M

1.4K

8.6K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $477M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.